Effect of Pharmaceutical Care Provision on Patients with Superficial Fungal Skin Infection Patients at Drug Stores
Article Sidebar
Main Article Content
Abstract
Introduction: Superficial fungal infections are a common disease presented by patients in drugstores. A community pharmacist should provide information about the disease, dispense appropriate antifungal drugs and identify and correct drug related problems. The objectives: To examine the effects of pharmaceutical care provision in patients with superficial fungal infections at four community pharmacies. Material and Methods: This quasi-experimental study investigated the knowledge about drugs and disease, treatment outcomes, relapse and compliance by comparing between a control group (patients who received routine service) and an intervention group (patients who received pharmaceutical care) between December 2009 and November 2010 in Mahasarakham. Fifty-seven patients with superficial fungal infections were recruited into the study; 30 patients were in the study group and 27 patients in the control group. Results: No significant differences were found in patients’ characteristics between the groups. After pharmaceutical care provision, post test score of the experimental group was significantly higher than pre-test score (p<0.05) and significantly higher than the control group (p<0.05). On the other hand, there were no significant cure rate of patient in the experimental group were significantly higher than the control group (p<0.05). In addition, higher compliance and lower recurrence were found in the treatment group with significance difference (p<0.05). Conclusion: Pharmaceutical care provision for superficial fungal infections could increase knowledge about drugs and disease for patients who receive service, and increase compliance and lower recurrence rate.
Article Details
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Atherton-Naji A, Hamilton R, Riddle W, Naji S. Improving adherence to antidepressant drug treatment in primary care: a feasibility study for a randomized controlled trial of education intervention. Primary Care Psychiatry 2001; 7: 61–7.
Barnett MJ, Frank J, Wehring H, et al. Analysis of Pharmacist-Provided Medication Therapy Management (MTM) Services in Community Pharmacies Over 7 Years. J Manag Care Pharm 2009;15: 18-31
Brown TE, Chin TW. Superficial Fungal Infection. In DiPiro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach. 7th ed. Appleton&Lange: Stamford; 2008. 1957.
Chang CH. Xu YY, Kurth T, Orav JE, Chan AK. The safety of oral antifungal treatment for superficial dermatophytosis and onychomycosis : A meta-analysis. Am J Med 2007: 9 : 791-8 .
Chirawatkul A. Statistics for Health Science Research. Bangkok : Wittayaphat press; 2010.
Eussen SR, Elst ME, Klungel OH, et al. A pharmaceutical care program to improve adherence to statin therapy:A randomized controlled trial . Ann Pharmacother 2010: 1905-13.
Gaudet LM, Kives S, Hahn PM., Reid RL. What women believe about oral contraceptives and the effect of counseling. Contraception 2004; 69: 31–6.
Hammarstrom B, Wessling A, Nilsson JL. Pharmaceutical care for patients with skin disease : a campaign year at Swedish pharmacies. J Clin Pharm Ther 1995; 20: 327-34.
Hanlon JT, Lindblad CL, Gray SL, Can clinical pharmacy service have a positive impact on drug-related problems and health outcome in community-based older adults. Am J Geriatr Pharmacother 2004; 2: 3-13.
Havlickova B. Epidemiological trends in skin mycoses worldwide. Mycose 2008; 51: 2-15 .
Haynes RB. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;11: 106.
Heather MP, Garg AX and Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002;22:286-8.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hos Pharm 1990; 47 : 533-43.
Huddson M. Antifungal resistance and over the counter availability in the UK : a current perspective. J Antimicrob Chemoter 2001;48: 354-60.
Huddson M. The effect of community intervention trial on parental knowledge and Awareness of antibiotic resistance and appropriate antibiotic use in children. Pediatrics 2001;1: 1-7.
Hywel WH. Epidermiology of skin disease in Europe. EJD 2008;51: 2-15.
Robert AS. Superficial fungal infecions. Lancet 2004:364:1173-81.
Ungpakorn R. Mycoses in Thailand : Current Concerns. Jpn J Med Mycol 2005;45: 81-6.
Uttarin P, Kanjanasilp J, Sa-ngasri P. Effects of Pharmaceutical Care in Patients with Dyspepsia in a Community Pharmacy. IJPS 2010;6: 15-25.
Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002; 288: 1594–602.